Public professional speaker profile

Kelly Fair

Partner in Dentons' Cannabis and Health Care practices

Dentons

Source description

Kelly Fair is a partner in Dentons' Cannabis and Health Care practices and focuses on regulatory compliance, corporate transactions, corporate governance, and public policy, primarily in the cannabis and hemp industries. With 18 years of in-house and major law firm experience advising high-growth, disruptor industry companies and boards, Kelly has an understanding and appreciation of the broad range of legal, regulatory, operational and financial considerations involved when working with clients in the cannabis and hemp markets. Prior to rejoining Dentons, Kelly served as Canopy Growth Corporation's first-ever US General Counsel and Vice President of US and European affairs. There, she managed all of the company’s US and European legal and policy affairs, global mergers and acquisitions, corporate governance and continuous disclosure. While navigating the limitations of US federal and securities laws related to cannabis and hemp-derived products, Kelly helped bring Canopy’s hemp-derived CBD products to market to the US market, including launching Canopy’s Martha Stewart brand. Kelly also developed innovative deal structures that grew the company’s US footprint and built a first-class US business, which led to creation of Canopy's newly formed US-domiciled holding company, Canopy USA, LLC. Within Dentons, Kelly serves as Canopy USA, LLC’s external US General Counsel, providing all legal services to the holding company and its $600M operating assets under management. Kelly also provides legal counsel to the Commonwealth Project, the primary lobbying organization engaged directly with CMS on the Substance Access BEI program and brings insight into the legislative and regulatory dynamics shaping program expansion.

View publisher source ↗

Sessions featuring this speaker

sessionThu Dec 03

Covered or Cut Off: Cracking Cannabis Insurance and Patient Access

10:50 AM – 11:30 AM

Breakout Session Room 4 - N115

Alleh Lindquist · Kelly Fair

Pharmaceutical & Clinical Research

Insurance remains one of the hardest walls between cannabis and the patients who need it. Despite expanding medical programs, most plans still refuse to cover cannabis products, leaving patients to pay out of p…

View details ↗